Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers
- SCWorx Corp. (NASDAQ:WORX) shares jumped 281% to $0.8396.
- EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares jumped 112.8% to $23.56. EdtechX Holdings Acquisition Corp II reported an amendment to extend date to consummate a business combination from June 15, 2023 to Dec. 15, 2023.
- VIQ Solutions Inc. (NASDAQ:VQS) rose 35% to $0.3551 after the company partnered with Justice AV Solutions to bring AI-generated draft transcripts of courtroom proceedings.
- Axcella Health Inc. (NASDAQ:AXLA) gained 34% to $0.4089.
- Leju Holdings Limited (NYSE:LEJU) gained 27.1% to $3.71 after gaining 15% on Wednesday.
- Staffing 360 Solutions, Inc. (NASDAQ:STAF) gained 27% to $0.84.
- Sonic Foundry, Inc. (NASDAQ:SOFO) surged 26.1% to $1.3750 after the company announced its Vidable business, which offers AI-powered analytics for video, will team up with its Video Solutions business to develop an offering focused on supporting the events market.
- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 20.3% to $3.08 on new US patent covering continued momentum toward domestic non-flammable lithium battery production.
- Nikola Corporation (NASDAQ:NKLA) gained 19.9% to $1.2950 after jumping 18% on Wednesday.
- AMMO, Inc. (NASDAQ:POWW) surged 16.9% to $2.3850 following strong quarterly results.
- Corner Growth Acquisition Corp. (NASDAQ:COOL) gained 15.9% to $12.19.
- IO Biotech, Inc. (NASDAQ:IOBT) surged 15.2% to $1.8550.
- MicroVision, Inc. (NASDAQ:MVIS) shares gained 14.9% to $5.28 after the company withdrew its proposed public offering of common stock.
- Jeffs' Brands Ltd (NASDAQ:JFBR) climbed 13.3% to $0.88.
- Opera Limited (NASDAQ:OPRA) gained 11.6% to $20.83. Opera initiated semi-annual dividend of $0.40 per share.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares gained 10.4% to $1.2950 after climbing 23% on Wednesday.
- InnSuites Hospitality Trust (NYSE:IHT) gained 10.3% to $2.99.
- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) climbed 10.1% to $11.51. Aldeyra Therapeutics said Phase 3 INVIGORATE-2 Trial of reproxalap ophthalmic solution for allergic conjunctivitis achieved statistical significance for the primary endpoint and all secondary endpoints.
- Patterson-UTI Energy, Inc. (NASDAQ:PTEN) gained 9.8% to $12.23 after the company and NexTier Oilfield Solutions entered a definitive merger agreement to combine in an all-stock merger of equals transaction.
- Beneficient (NASDAQ:BENF) rose 7.6% to $5.94.
- The Goodyear Tire & Rubber Company (NASDAQ:GT) gained 7.5% to $14.18. Traders circulated rumor that an imminent takeover may happen.
Losers
- Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares tumbled 58.3% to $3.9850 after the FDA issued a partial clinical hold pausing new patient enrollment in the company's UP-NEXT and UPGRADE-A ovarian cancer trials.
- Bone Biologics Corporation (NASDAQ:BBLG) fell 54.3% to $1.80 after the company priced its public offering of 2.54 million shares at $1.97 per share.
- OncoSec Medical Incorporated (NASDAQ:ONCS) fell 47.7% to $0.2240. OncoSec Medical filed voluntary petition for relief under bankruptcy. The company also said Robert Arch tendered his resignation as company's President and CEO effective on June 14.
- Top KingWin Ltd (NASDAQ:TCJH) fell 46.6% to $4.97.
- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) declined 26.5% to $0.5387 after posting a wider FY loss.
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) dropped 26% to $2.4685. Corvus Pharmaceuticals said updated data from CPI-818 Phase 1/1B Trial in solid & hematological cancers continues to demonstrate the potential of ITK inhibition and absolute lymphocyte count biomarker in T Cell Lymphoma.
- DatChat, Inc (NASDAQ:DATS) fell 23% to $0.6389 after jumping around 90% on Wednesday.
- Getaround, Inc. (NYSE:GETR) dropped 17.1% to $0.3649. Axle, the leading universal API for insurance data, reported a partnership with Getaround, the world's first connected carsharing marketplace.
- Editas Medicine, Inc. (NASDAQ:EDIT) shares fell 15.2% to $9.41. Editas Medicine priced an underwritten public offering of 12.5 million shares at $10 per share.
- ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) dropped 15.1% to $0.3157.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 15.1% to $0.1485.
- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 13% to $0.5901. Processa Pharmaceuticals said that CEO David Young, Pharm.D., Ph.D. will present at the MedInvest Oncology Investor Conference being held on June 21-22, 2023 in Boston, MA.
- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) dropped 11.3% to $90.63.
- SEALSQ Corp (NASDAQ:LAES) fell 10.7% to $15.83 after gaining over 74% on Wednesday.
- Greenidge Generation Holdings Inc. (NASDAQ:GREE) shares fell 10.5% to $2.1489 after jumping 50% on Wednesday.
- Vertex, Inc. (NASDAQ:VERX) fell 10.4% to $20.17.
- Gambling.com Group Limited (NASDAQ:GAMB) shares dipped 10.4% to $9.85 after the company reported pricing of secondary offering of ordinary shares by selling shareholders.
- Blue Water Biotech, Inc. (NASDAQ:BWV) shares dropped 10.2% to $15.83. Blue Water Biotech shares gained 62% on Wednesday after the company acquired six FDA-approved drugs across various treatment areas.
- John Wiley & Sons, Inc. (NYSE:WLY) fell 9.7% to $33.06 following fourth-quarter results.
- Aurora Mobile Limited (NASDAQ:JG) shares dropped 7.6% to $0.2834 after reporting first-quarter results.
- Vera Therapeutics, Inc. (NASDAQ:VERA) fell 6.9% to $12.43.
Now Read This: Bitcoin Tumbles Below $25,000 Following Fed's Decision; Injective, Aave Among Top Losers